Enavate Sciences Gp, LLC filed its 13F report for Q4 2025 on February 17, 2026. The portfolio totaled 506.78 M reflecting a +54.73% change from the prior quarter, spanning 7 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. No significant position changes were reported during the quarter.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Enavate Sciences Gp submitted their Form 13F-HR for the Q4 2025 period on 02/17/2026. This was the only submission for the quarter.
In the Q4 2025 filing, Enavate Sciences Gp reported a managed portfolio value of 506.78 M, consisting of 7 individual positions.
This page displays the raw filing documents. To see which stocks Enavate Sciences Gp bought or sold during Q4 2025, please visit Enavate Sciences Gp's Portfolio Analysis page.